ANAL MARGIN SQUAMOUS CELL CARCINOMA
Clinical trials for ANAL MARGIN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL MARGIN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL MARGIN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less be more? new study tests gentler treatment for anal cancer
Disease control OngoingThis study looks at whether a lower dose of chemotherapy plus radiation can control early-stage anal cancer as well as the standard higher dose, while causing fewer side effects. About 252 adults with small tumors (4 cm or less) that haven't spread will take part. The goal is to …
Matched conditions: ANAL MARGIN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope: tailored therapy fights anal cancer in HIV patients
Disease control OngoingThis study tests a personalized approach for people with HIV who have anal cancer. Low-risk patients receive standard chemotherapy and radiation, while high-risk patients also get the immunotherapy drug nivolumab to help prevent the cancer from coming back. The goal is to see if …
Matched conditions: ANAL MARGIN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Immunotherapy after Chemo-Radiation may keep anal cancer at bay
Disease control OngoingThis study tests whether adding the immunotherapy drug nivolumab after standard chemoradiation can prevent anal cancer from coming back in patients with high-risk stage II-IIIB disease. About 344 adults with squamous cell carcinoma of the anus are enrolled. The main goal is to se…
Matched conditions: ANAL MARGIN SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 15:58 UTC